Project Grant R01MH137280
Award Date
8/1/25
Completion Date
4/30/30
Dollars Obligated
$768K
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Rhode Island, USA
Similar Awards
This federal Project Grant award of $2,210,865, provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), aims to identify unique neural and inflammatory mechanisms of depression in people living with HIV (PLWH). The University of California, Los Angeles (UCLA) will conduct a cross-sectional study to enroll PLWH who are depressed and non-depressed, as well as HIV-negative subjects who are depressed and non-depressed. The research...
The National Institute of Mental Health (NIMH) awarded a $780,447 Project Grant (CFDA 93.242 - Mental Health Research Grants) to Brigham & Women's Hospital Inc. to test a differentiated service delivery model called CARES-DSD to improve engagement and viral suppression among people with HIV who have experienced treatment interruptions in South Africa. The 5-year project will recruit 300 participants from an ongoing study and evaluate the effectiveness of the CARES-DSD intervention compared...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $194,157 to the Icahn School of Medicine at Mount Sinai to develop and pilot a novel intervention to treat post-COVID cognitive impairment and depression in patients. The intervention integrates cognitive rehabilitation based on goal management training and cognitive behavioral therapy, and is specifically adapted for ethnically diverse patients....
This federal Project Grant award, funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), aims to evaluate social brain function in people living with HIV (PWH). The $733,355 award, effective March 1, 2025 through January 31, 2030, will utilize well-validated fMRI paradigms to examine neural circuits and performance related to two core social cognitive constructs: perceiving social cues (e.g., facial expressions, prosody) and...
This federal Project Grant award of $240,750 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to promote access, engagement, coordination, and optimization of mental health services for preschoolers with mental health symptoms. The award recipient, Childrens Hospital Medical Center, will use the funding to tailor and pilot test the NTRI-MH intervention, which employs ethno-racially matched family navigators to increase...
This $103,948 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research on the impact of forced migration on HIV vulnerability and prevention among internally displaced adolescent girls and young women in Northern Mozambique. The project aims to (1) determine predictors of HIV vulnerability related to exposure to displacement-related stressors and mental health among this population, and (2) explore...
This federal Project Grant award, totaling $745,822.00 and provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), supports research to investigate the role of the PERK kinase in HIV-induced neuroinflammation and neurocognitive impairment (NCI) in people with HIV (PWH). The University of Pennsylvania, as the primary grantee, will use biochemical, cellular, and pharmacologic approaches to assess PERK's potential as a predictive...
This federal Project Grant award from the National Institutes of Health National Institute of Mental Health provides $6,499,884 to Yale University under the Mental Health Research Grants program (CFDA 93.242) to study the longitudinal nervous system consequences of SARS-CoV-2 in people with HIV-1 treated in early infection. The award will fund research from September 2022 to September 2025 to analyze pre- and post-COVID-19 data from a cohort of early antiretroviral therapy-treated people with...
This federal Project Grant award, funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), will support a research project titled "EARLY-PHASE PSYCHOSIS: PRACTICE-BASED RESEARCH TO IMPROVE TREATMENT OUTCOMES". The $1,659,568 award, effective June 2, 2025 through May 31, 2030, will enable the awardee, The Feinstein Institutes for Medical Research, to enroll an additional 625 participants from 13 clinics across 6 states in...
The National Institute of Mental Health (NIMH) awarded a $904,100 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to the Lovelace Biomedical Research Institute in Albuquerque, New Mexico. The grant, awarded on May 5, 2025, will fund a longitudinal study to develop algorithms that predict mental health functioning and related outcomes, such as recidivism and substance use relapse, in incarcerated women. The research will utilize multimodal data, including psychosocial,...